Mannkind: Peers

The FY2025 (Dec) proxy of Mannkind names 13 peer companies for pay. Pay versus performance data of Mannkind for that year is not on file, so it has no rank.

Pay peer group, FY2025 (Dec) proxy

INSMED
Krystal Biotech
Mirum Pharmaceuticals
Adma Biologics
Travere Therapeutics
Anika Therapeutics, Inc.Not disclosedNot disclosed
Biocryst PharmaceuticalsNot disclosedNot disclosed
Dynavax Technologies CorporationNot disclosedNot disclosed
Ironwood Pharmaceuticals, Inc.Not disclosedNot disclosed
Karyopharm Therapeutics Inc.Not disclosedNot disclosed
MacroGenics Inc.Not disclosedNot disclosed
Rigel Pharmaceuticals Inc.Not disclosedNot disclosed
Vanda Pharmaceuticals Inc.Not disclosedNot disclosed
13 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

Russell 3000 Pharmaceutical & Biotechnology Index (index)Not disclosedNot disclosed
1 company

Changes by year

FY2025 (Dec) proxy

  • AddedKrystal Biotechpay peer groupIn addition, the Compensation Committee added two companies that satisfied our criteria for peer companies: Krystal Biotech, Inc. and Travere Therapeutics, Inc
  • AddedTravere Therapeuticspay peer groupIn addition, the Compensation Committee added two companies that satisfied our criteria for peer companies: Krystal Biotech, Inc. and Travere Therapeutics, Inc
  • RemovedDeciphera Pharmaceuticals, Inc.pay peer groupBased on data compiled by Mercer and reviewed by the Compensation Committee during this process, the Compensation Committee determined that one company needed to be removed from the list: Deciphera Pharmaceuticals, Inc., which was acquired in 2024

FY2024 (Dec) proxy

  • RemovedAgenus Inc.pay peer groupBased on data compiled by Mercer and reviewed by the Compensation Committee during this process, the Compensation Committee determined that two companies needed to be removed from the list: Sangamo Therapeutics, Inc., who does not have a product on the market and does not employ a sales force and Agenus Inc., whose market value is outside our peer screening criteria and who also does not have a product on the market and does not employ a sales force
  • RemovedSangamo Therapeutics, Inc.pay peer groupBased on data compiled by Mercer and reviewed by the Compensation Committee during this process, the Compensation Committee determined that two companies needed to be removed from the list: Sangamo Therapeutics, Inc., who does not have a product on the market and does not employ a sales force and Agenus Inc., whose market value is outside our peer screening criteria and who also does not have a product on the market and does not employ a sales force

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.